Despite data gaps in many countries, the burden of sickle cell disease, especially in west and central Africa, underscores the urgent need to scale up newborn and early childhood screening, ...

ProteomeXchange’s 2026 update shows that global proteomics data sharing continues to accelerate, with more than 64,000 ...

Somewhere, a 17-year-old has built an artificial intelligence tool designed to identify malaria and other blood diseases from ...

Agreement advances Project 777-generated therapeutic candidates into external validation, marking an early commercial milestone for governed AI systems. DALLAS, TX ...

A new research project aims to develop the world’s first therapy to eliminate and prevent the spread of a toxic brain protein that drives Parkinson’s disease. Innovation Fund Denmark has invested DKK ...

A computational method called scSurv, developed by researchers at Institute of Science Tokyo, links individual cells to patient outcomes using widely available bulk RNA sequencing data. The approach ...

C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, highlighted the first use of its eMTBR-tau243 plasma assay in a Phase 3 dataset (Evoke ...

C2N Diagnostics Highlights First Use of Its eMTBR-tau243 Plasma Assay in Evoke/Evoke+ Phase 3 Dataset for Prediction of Cognitive and Functional Decline in Patients With Early Symptomatic Alzheimer’s ...

In medieval Denmark, people could pay for more prestigious graves closer to the church — a sign of wealth and status. But when researchers examined hundreds of skeletons, they discovered something ...

CMS will award up to $100 million to fund as many as 30 pilot programs through its voluntary initiative focused on lifestyle medicine. Six things to know: 1. The agency plans to award up to 30 ...

ctDNA monitoring of FGFR3-altered metastatic urothelial cancer treated with dabogratinib (formerly TYRA-300) in the SURF301 trial. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary ...